Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$226.52 - $324.64 $40,547 - $58,110
179 Added 0.46%
38,707 $12.6 Million
Q1 2023

May 15, 2023

BUY
$229.06 - $278.01 $110,177 - $133,722
481 Added 1.26%
38,528 $9.02 Million
Q4 2022

Feb 14, 2023

SELL
$164.02 - $259.76 $2.31 Million - $3.66 Million
-14,083 Reduced 27.02%
38,047 $9.58 Million
Q3 2022

Nov 14, 2022

BUY
$170.68 - $226.46 $177,677 - $235,744
1,041 Added 2.04%
52,130 $9.25 Million
Q2 2022

Aug 15, 2022

BUY
$147.53 - $266.6 $2.25 Million - $4.06 Million
15,239 Added 42.51%
51,089 $9.33 Million
Q1 2022

May 13, 2022

SELL
$193.94 - $261.91 $2.21 Million - $2.99 Million
-11,413 Reduced 24.15%
35,850 $9.2 Million
Q4 2021

Feb 14, 2022

BUY
$207.57 - $280.17 $456,446 - $616,093
2,199 Added 4.88%
47,263 $10.9 Million
Q3 2021

Nov 03, 2021

BUY
$170.0 - $258.58 $203,660 - $309,778
1,198 Added 2.73%
45,064 $10.5 Million
Q2 2021

Aug 12, 2021

SELL
$164.93 - $242.23 $2.82 Million - $4.14 Million
-17,095 Reduced 28.04%
43,866 $8.48 Million
Q1 2021

May 13, 2021

BUY
$182.45 - $249.25 $3.01 Million - $4.11 Million
16,495 Added 37.1%
60,961 $12.6 Million
Q4 2020

Feb 12, 2021

SELL
$119.35 - $200.46 $93,093 - $156,358
-780 Reduced 1.72%
44,466 $8.36 Million
Q3 2020

Nov 13, 2020

BUY
$87.5 - $130.91 $2.94 Million - $4.39 Million
33,551 Added 286.88%
45,246 $5.84 Million
Q2 2020

Aug 14, 2020

BUY
$49.5 - $97.93 $17,523 - $34,667
354 Added 3.12%
11,695 $1.02 Million
Q1 2020

May 14, 2020

BUY
$41.62 - $89.92 $134,682 - $290,981
3,236 Added 39.93%
11,341 $683,000
Q4 2019

Feb 11, 2020

SELL
$52.12 - $75.0 $25,851 - $37,200
-496 Reduced 5.77%
8,105 $601,000
Q3 2019

Nov 12, 2019

BUY
$61.02 - $70.19 $524,833 - $603,704
8,601 New
8,601 $524,000

Others Institutions Holding INSP

About Inspire Medical Systems, Inc.


  • Ticker INSP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,788,600
  • Market Cap $5.44B
  • Description
  • Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...
More about INSP
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.